Clinolipid FDA Approval History
FDA Approved: Yes (First approved October 3, 2013)
Brand name: Clinolipid
Generic name: lipid injectable emulsion
Dosage form: for Intravenous Use
Company: Baxter International Inc.
Treatment for: Parenteral Nutrition
Clinolipid (lipid injectable emulsion) is an intravenous fat supplement used for parenteral nutrition.
- Clinolipid is indicated in adults and pediatric patients, including term and preterm neonates, as a source of calories and essential fatty acids for parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Development timeline for Clinolipid
| Date | Article |
|---|---|
| May 13, 2024 | Approval Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication |
| Oct 4, 2013 | Approval FDA Approves Clinolipid for Intravenous Nutrition |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
